Last reviewed · How we verify
Oral antibiotic therapy
At a glance
| Generic name | Oral antibiotic therapy |
|---|---|
| Also known as | Antibiotics, Probiotics, dietary factors, cosmetics and adjuvants |
| Sponsor | Rigshospitalet, Denmark |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Comparison of Oral Antibiotics For Bone Infections of the Leg and Foot (PHASE4)
- A Study of Doxycycline to Treat Chlamydial Infection (PHASE4)
- Acupuncture for Colorectal sUrgery Recovery Enhancement: A Randomized Controlled Trial Evaluating Gastrointestinal Functional Recovery After Minimally Invasive Resection (NA)
- Effect of Oral Microbiota on MDRO Decolonization (PHASE1, PHASE2)
- Arthrosemid vs. Steroid for the Management Knee Osteoarthritis (PHASE4)
- The Personalised Antibiotic Duration for Cellulitis (PAD-C) Study
- Safety and Tolerability of Metformin in People With Tuberculosis (TB) and Human Immunodeficiency Virus (HIV) (PHASE2)
- Utility of Single-dose Oral Antibiotic Prophylaxis in Prevention of Surgical Site Infection in Dermatologic Surgery (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Oral antibiotic therapy CI brief — competitive landscape report
- Oral antibiotic therapy updates RSS · CI watch RSS
- Rigshospitalet, Denmark portfolio CI